HOME >> MEDICINE >> NEWS
MGH researchers identify angiogenesis inhibitor in gallbladder cancer

Researchers at the Massachusetts General Hospital (MGH) have discovered that a cellular growth factor called TGF-beta-1 has a previously unsuspected role in regulating the growth of blood vessels associated with metastatic gallbladder cancer. They also report finding that, in animal studies of the development of blood vessels (angiogenesis) associated with cancer, model systems in which tumor cells are grown in an unnatural location - for example, gallbladder cancer cells grown under the skin - may produce misleading results.

The study's results, appearing in the October issue of Nature Medicine, may someday lead to strategies to prevent the growth of metastases from gallbladder cancer, a serious problem in treatment of the disease. They also add further complexity to current knowledge about factors that regulate angiogenesis and their role in the growth and spread of cancer.

"We discovered that suppression of the growth of a secondary tumor [metastases] by antiangiogenic factors released by the primary tumor depended on the primary tumor's growing in the right environment," says Rakesh Jain, PhD, director of the Steele Laboratory for Tumor Biology at the MGH and the study's senior author. "That may have implications for the identification of anti-angiogenesis agents that may be useful for cancer treatment."

The research team focused on gallbladder cancer, which is diagnosed in more than 6,000 Americans each year, because of a frustrating property of the disease. As long as the primary tumor remains in the gallbladder, metastases - pockets of cancer that develop in other parts of the body - are few and very small. But soon after the primary tumor is surgically removed, metastases appear and grow quickly. As a result, only about 5 percent of patients having the surgery, which currently is the only treatment for the disease, survive for five years or more.

This apparent suppression of the growth of metastases by the presence of a primary
'"/>

Contact: Susan McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
28-Sep-1999


Page: 1 2 3 4

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
Cached News: